[HTML][HTML] Novel strategies for the prevention and treatment of biofilm related infections

M Chen, Q Yu, H Sun - International journal of molecular sciences, 2013 - mdpi.com
Biofilm formation by human bacterial pathogens on implanted medical devices causes major
morbidity and mortality among patients, and leads to billions of dollars in healthcare cost …

Infections associated with medical devices: pathogenesis, management and prophylaxis

C Von Eiff, B Jansen, W Kohnen, K Becker - Drugs, 2005 - Springer
The insertion or implantation of foreign bodies has become an indispensable part in almost
all fields of medicine. However, medical devices are associated with a definitive risk of …

Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update

J Marschall, LA Mermel, M Fakih… - Infection Control & …, 2014 - cambridge.org
Previously published guidelines are available that provide comprehensive
recommendations for detecting and preventing healthcare-associated infections (HAIs). The …

Catheter impregnation, coating or bonding for reducing central venous catheter‐related infections in adults

NM Lai, N Chaiyakunapruk, NA Lai… - Cochrane Database …, 2016 - cochranelibrary.com
Background The central venous catheter (CVC) is essential in managing acutely ill patients
in hospitals. Bloodstream infection is a major complication in patients with a CVC. Several …

Infecciones relacionadas con el uso de los catéteres vasculares

C Ferrer, B Almirante - Enfermedades infecciosas y microbiología clínica, 2014 - Elsevier
Las infecciones relacionadas con los catéteres vasculares son un problema de especial
relevancia por su frecuencia, por su morbimortalidad y por ser procesos clínicos …

Anti-biofilm properties of chitosan-coated surfaces

RP Carlson, R Taffs, WM Davison… - Journal of Biomaterials …, 2008 - Taylor & Francis
Surfaces coated with the naturally-occurring polysaccharide chitosan (partially deacetylated
poly N-acetyl glucosamine) resisted biofilm formation by bacteria and yeast. Reductions in …

Antimicrobial central venous catheters in adults: a systematic review and meta-analysis

AL Casey, LA Mermel, P Nightingale… - The Lancet infectious …, 2008 - thelancet.com
Several antimicrobial central venous catheters (CVCs) are available. We did a meta-
analysis to assess their efficacy in reducing microbial colonisation and preventing catheter …

Intravenous therapy

C Waitt, P Waitt, M Pirmohamed - Postgraduate medical journal, 2004 - academic.oup.com
Intravenous administration of fluids, drugs, and nutrition is very common in hospitals.
Although insertion of peripheral and central cannulae and subsequent intravenous therapy …

[HTML][HTML] Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies

RS Boersma, KSG Jie, A Verbon, ECM Van Pampus… - Annals of oncology, 2008 - Elsevier
Central venous catheters (CVCs) have considerably improved the management of patients
with hematological malignancies, by facilitating chemotherapy, supportive therapy and …

Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity

HS Sader, KA Fedler, RP Rennie… - Antimicrobial agents …, 2004 - Am Soc Microbiol
The activity of omiganan pentahydrochloride (formerly MBI 226; a synthetic cationic peptide)
was assessed against 1,437 recent clinical bacterial isolates and 214 recent clinical yeast …